Pfizer Inc. (ETR:PFE)
 21.41
 +0.20 (0.94%)
  Nov 4, 2025, 10:39 AM CET
Pfizer Revenue
Pfizer had revenue of $14.65B USD in the quarter ending June 29, 2025, with 10.31% growth. This brings the company's revenue in the last twelve months to $63.83B, up 13.53% year-over-year. In the year 2024, Pfizer had annual revenue of $63.63B with 6.84% growth.
Revenue (ttm) 
 $63.83B
Revenue Growth 
 +13.53%
P/S Ratio 
 2.23
Revenue / Employee 
 $788.06K
Employees 
 81,000
Market Cap 
121.60B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 63.63B | 4.07B | 6.84% | 
| Dec 31, 2023 | 59.55B | -41.62B | -41.14% | 
| Dec 31, 2022 | 101.18B | 19.89B | 24.46% | 
| Dec 31, 2021 | 81.29B | 39.64B | 95.16% | 
| Dec 31, 2020 | 41.65B | 746.00M | 1.82% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Bayer Aktiengesellschaft | 46.17B | 
| Siemens Healthineers AG | 23.38B | 
| Fresenius SE & Co. KGaA | 22.28B | 
| Merck KGaA | 21.22B | 
| Fresenius Medical Care AG | 19.52B | 
| Sartorius Aktiengesellschaft | 3.52B | 
| Redcare Pharmacy NV | 2.82B | 
| Fielmann Group AG | 2.40B | 
Pfizer News
- 4 hours ago - Novo Nordisk CEO faces baptism of fire amid board shakeup, Pfizer fight - Reuters
 - 13 hours ago - Pre-Market Earnings Report for November 4, 2025 : SHOP, UBER, ETN, PFE, SPOT, RACE, APO, MAR, TRI, ZTS, MPC, MPLX - Nasdaq
 - 14 hours ago - Pfizer (PFE) Files Second Lawsuit to Block Novo Nordisk's Bid for Metsera - GuruFocus
 - 15 hours ago - Gold Edges Higher; ISM Manufacturing PMI Falls In October - Benzinga
 - 16 hours ago - Did Novo Nordisk Just Say "Checkmate" to Pfizer? - The Motley Fool
 - 16 hours ago - Pfizer (PFE) Faces Q3 Earnings Amid Market Challenges and Strategic Moves - GuruFocus
 - 17 hours ago - Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo - Investor's Business Daily
 - 17 hours ago - Pfizer Q3 Earnings Preview: Results to test recovery hopes amid TrumpRx deal, Metsera dispute - Seeking Alpha